Top compounds associated with response to EIF2S3


Feature Type Standardized
Nominal ANOVA
mRNA silmitasertib CTRPv2 pan-cancer AAC -0.078 0.05
mRNA erastin CTRPv2 pan-cancer AAC 0.071 0.05
mRNA GSK525762A CTRPv2 pan-cancer AAC -0.06 0.05
mRNA Doxorubicin CTRPv2 pan-cancer AAC 0.061 0.05
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC 0.06 0.05
mRNA triptolide CTRPv2 pan-cancer AAC 0.07 0.06
mRNA SB 505124 GDSC1000 pan-cancer AAC 0.068 0.06
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.07 0.06
mRNA CID-5951923 CTRPv2 pan-cancer AAC -0.076 0.06
mRNA I-BET151 CTRPv2 pan-cancer AAC -0.061 0.06
Download CSV